1 :

Hint : 🖍️ Hydration helps eliminate uric acid

Correct Answers:

  • Drink at least 8 cups (1,920 mL) of water per day.

Rationale :

🖍️ Gouty arthritis results from deposition of monosodium urate crystals in joints due to elevated serum uric acid levels.

🖍️ Maintaining adequate hydration promotes renal excretion of uric acid and can help decrease the risk of uric acid crystal formation.

🖍️ Drinking at least 8 cups (1,920 mL) of water daily, when not contraindicated, helps maintain sufficient urine production.

🖍️ Increased urinary output assists the kidneys in eliminating uric acid from the body.

🖍️ Adequate fluid intake can also reduce the risk of developing uric acid kidney stones, which may occur in clients with hyperuricemia.

🖍️ During an acute gout attack, prescribed colchicine and indomethacin help decrease the inflammatory response and associated joint pain.

🖍️ The client should also follow dietary recommendations that limit excessive intake of high-purine foods, which can contribute to increased uric acid production.

🖍️ Therefore, encouraging adequate water intake is an important component of discharge teaching for a client with gout.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

2 :

74-year-old male client comes to emergency department (ED) with symptoms of feeling weak, extreme tiredness and lack of appetite for 4 days.

Nurses' Notes

0800

 

Client has a diagnosis of end stage renal disease (ESRD) and was supposed to go to the hospital to start dialysis but did not have transportation. Peripheral IV (PIV) access device inserted, and STAT laboratory specimens drawn. Connected to continuous cardiac monitoring.

 

0810

 

Mucous membranes dry. Capillary refill greater than 3 seconds. Able to void, but urinary output less than 100 mL/24 hours. Weight 188 lb (85.45 kg).

0810

Vital signs

Heart rate: 126 beats/minute and irregular

Respirations: 24 breaths/minute and shallow

Blood pressure: 166/104 mm Hg

Oxygen saturation: 92% on room air

0800

Admit to hospital for insertion of subclavian dialysis catheter. Send to interventional radiology for insertion STAT

Begin hemodialysis as soon as catheter in place and verified by x-ray

Repeat basic metabolic panel (BMP) and complete blood count (CBC) at the end of first dialysis and every six hours thereafter

Weigh daily

Laboratory TestResultReference Range
Basic Metabolic Panel (BMP)  
Potassium6.6 mEq/L (6.6 mmol/L)3.5 to 5 mEq/L (3.5 to 5 mmol/L)
Sodium130 mEq/L (130 mmol/L)136 to 145 mEq/L (136 to 145 mmol/L)
Creatinine1.4 mg/dL (123.8 μmol/L)0.5 to 1.1 mg/dL (44 to 97 μmol/L)
Blood urea nitrogen (BUN)20 mg/dL (7.14 mmol/L)10 to 20 mg/dL (3.6 to 7.1 mmol/L)
Magnesium6 mEq/L (3 mmol/L)1.3 to 2.1 mEq/L (0.65 to 1.05 mmol/L)
pH7.337.35 to 7.45
PaCO₂25 mm Hg35 to 45 mm Hg
HCO₃⁻18 mEq/L (18 mmol/L)21 to 28 mEq/L (21 to 28 mmol/L)
PaO₂80 mm Hg80 to 100 mm Hg

For each finding click to highlight the emergency department (ED) notation that requires immediate follow up. Each finding may support more than one ED notation. Each category must have at least one response option selected.

Findings & ED Notation Vital Signs Heart rate 126 beats/minute and irregular Capillary refill greater than 3 seconds Blood pressure 166/104 mm Hg Laboratory Basic Metabolic Panel (BMP) Potassium 6.6 mEq/L (6.6 mmol/L) Blood urea nitrogen (BUN) 20 mg/dL (7.14 mmol/L) Creatinine 1.4 mg/dL (0.23 mmol/L) Arterial Blood Gas (ABG) PaCO2 25 mm Hg pH 7.33 PaO2 80 mm Hg

Hint : 🌹 Prioritize potassium, rhythm, perfusion, acidosis

Correct Highlights :
  • Heart rate 126 beats/minute and irregular
  • Capillary refill greater than 3 seconds
  • Blood pressure 166/104 mm Hg
  • Potassium 6.6 mEq/L (6.6 mmol/L)
  • PaCO2 25 mm Hg
  • pH 7.33
Rationale :

🌹 The irregular tachycardia of 126/min requires immediate attention because the client has severe hyperkalemia (K⁺ 6.6 mEq/L), which can produce life-threatening cardiac dysrhythmias.

🌹 Capillary refill greater than 3 seconds indicates impaired peripheral perfusion and is concerning when combined with tachycardia and dry mucous membranes.

🌹 A blood pressure of 166/104 mm Hg represents significant hypertension and requires follow-up, particularly in a client with ESRD and severe electrolyte abnormalities.

🌹 A potassium level of 6.6 mEq/L represents severe hyperkalemia and is the most immediately life-threatening laboratory abnormality because of the risk for fatal cardiac dysrhythmias.

🌹 The BUN of 20 mg/dL is at the upper limit of the provided reference range and therefore is not an immediate abnormal finding.

🌹 Although the creatinine of 1.4 mg/dL is elevated above the provided reference range, it does not represent the most immediate threat compared with severe hyperkalemia and cardiac instability.

🌹 The pH of 7.33 and HCO₃⁻ of 18 mEq/L indicate metabolic acidosis, while the PaCO₂ of 25 mm Hg reflects respiratory compensation and should be evaluated as part of the client's acid-base disturbance.

🌹 A PaO₂ of 80 mm Hg is at the lower boundary of the provided normal range and therefore is not itself an immediate abnormal ABG finding.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

3 :

74-year-old male client comes to emergency department (ED) with symptoms of feeling weak, extreme tiredness and lack of appetite for 4 days.

0800

 

Client has a diagnosis of end stage renal disease (ESRD) and was supposed to go to the hospital to start dialysis but did not have transportation. Peripheral IV (PIV) access device inserted, and STAT laboratory specimens drawn. Connected to continuous cardiac monitoring.

 

0810

 

Mucous membranes dry. Capillary refill greater than 3 seconds. Able to void, but urinary output less than 100 mL/24 hours. Weight 188 lb (85.45 kg).

 

1000

 

A Client states, "My heart feels funny and my chest hurts." Notified healthcare provider (HCP). Received prescription for care.

 

1100

 

Electrocardiogram (ECG) shows elevated T waves and dysrhythmia. Polystyrene sulfonate 50 grams administered via rectum. Nebulizer treatment with albuterol 10 mg started. Placed on continuous monitoring

0810

Vital signs

Heart rate: 126 beats/minute and irregular

Respirations: 24 breaths/minute and shallow

Blood pressure: 166/104 mm Hg

Oxygen saturation: 92% on room air

 

1000

 

Vital signs

Heart rate: 120 beats/minute and irregular

Blood pressure: 170/108 mm Hg

0800

Admit to hospital for insertion of subclavian dialysis catheter. Send to interventional radiology for insertion STAT

Begin hemodialysis as soon as catheter in place and verified by x-ray

Repeat basic metabolic panel (BMP) and complete blood count (CBC) at the end of first dialysis and every six hours thereafter

Weigh daily

Laboratory TestResultReference Range
Basic Metabolic Panel (BMP)  
Potassium6.6 mEq/L (6.6 mmol/L)3.5 to 5 mEq/L (3.5 to 5 mmol/L)
Sodium130 mEq/L (130 mmol/L)136 to 145 mEq/L (136 to 145 mmol/L)
Creatinine1.4 mg/dL (123.8 μmol/L)0.5 to 1.1 mg/dL (44 to 97 μmol/L)
Blood urea nitrogen (BUN)20 mg/dL (7.14 mmol/L)10 to 20 mg/dL (3.6 to 7.1 mmol/L)
Magnesium6 mEq/L (3 mmol/L)1.3 to 2.1 mEq/L (0.65 to 1.05 mmol/L)
Arterial Blood Gas  
pH7.337.35 to 7.45
PaCO₂25 mm Hg35 to 45 mm Hg
HCO₃⁻18 mEq/L (18 mmol/L)21 to 28 mEq/L (21 to 28 mmol/L)
PaO₂80 mm Hg80 to 100 mm Hg

The nurse determines that the client's symptoms of chest pain are caused by , The client's is related to the history of renal disease and prescription to decrease the potassium levels

Hint : ♦️ Peaked T waves suggest hyperkalemia

Correct Answers

  • Blank 1 Correct Option: heart
  • Blank 2 Correct Option: elevated potassium
  • Blank 3 Correct Option: lisinopril
Rationale :

♦️ The client's potassium is severely elevated at 6.6 mEq/L, indicating clinically significant hyperkalemia.

♦️ Hyperkalemia alters cardiac electrical conduction and can cause dangerous dysrhythmias.

♦️ The ECG findings of elevated/peaked T waves and dysrhythmia are characteristic cardiac manifestations of hyperkalemia.

♦️ The client's statement that the heart “feels funny,” combined with chest pain and an irregular tachycardia, supports a cardiac rhythm disturbance rather than anxiety or nonspecific pain.

♦️ ESRD markedly reduces renal potassium excretion, making hyperkalemia a major complication.

♦️ Lisinopril, an ACE inhibitor, can further increase potassium by decreasing aldosterone-mediated potassium excretion.

♦️ Lorazepam treats anxiety and does not explain or correct the client's hyperkalemia, while flecainide is an antiarrhythmic and is not used to lower potassium.

♦️ The prescribed albuterol and sodium polystyrene sulfonate, followed by urgent dialysis, are consistent with treatment directed toward the client's severe hyperkalemia.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

🚀 Upgrade and Unlock all Questions !
4 :

74-year-old male client comes to emergency department (ED) with symptoms of feeling weak, extreme tiredness and lack of appetite for 4 days.

0800

 

Client has a diagnosis of end stage renal disease (ESRD) and was supposed to go to the hospital to start dialysis but did not have transportation. Peripheral IV (PIV) access device inserted, and STAT laboratory specimens drawn. Connected to continuous cardiac monitoring.

 

0810

 

Mucous membranes dry. Capillary refill greater than 3 seconds. Able to void, but urinary output less than 100 mL/24 hours. Weight 188 lb (85.45 kg).

 

1000

 

A Client states, "My heart feels funny and my chest hurts." Notified healthcare provider (HCP). Received prescription for care.

 

1100

 

Electrocardiogram (ECG) shows elevated T waves and dysrhythmia. Polystyrene sulfonate 50 grams administered via rectum. Nebulizer treatment with albuterol 10 mg started. Placed on continuous monitoring

0810

Vital signs

Heart rate: 126 beats/minute and irregular

Respirations: 24 breaths/minute and shallow

Blood pressure: 166/104 mm Hg

Oxygen saturation: 92% on room air

 

1000

 

Vital signs

Heart rate: 120 beats/minute and irregular

Blood pressure: 170/108 mm Hg

 

1300

Vital signs

Heart rate: 108 beats/minute and continues to be irregular

Respirations: 20 breaths/minute

Blood pressure: 152/94 mm Hg

0800

Admit to hospital for insertion of subclavian dialysis catheter. Send to interventional radiology for insertion STAT

Begin hemodialysis as soon as catheter in place and verified by x-ray

Repeat basic metabolic panel (BMP) and complete blood count (CBC) at the end of first dialysis and every six hours thereafter

Weigh daily

 

1000

12-lead electrocardiogram (ECG) STAT

STAT electrolyte panel

Administer polystyrene sulfonate 50 g via rectum

Administer albuterol 10 mg nebulize treatment over 10 to 15 minutes x 1

Labetalol 20 mg IV push (IVP) now. May repeat dose in 20 minutes if needed. Blood pressure goal is less than 150/90

 

1500

Morphine 1 mg IVP now

Transfer to dialysis as soon as unit can start dialysis

 

Imaging Studies 

Tunneled subclavian 16 French (Fr) triple lumen dialysis catheter placed in interventional radiology. Placement confirmed via chest x-ray.

Laboratory TestResultReference Range
Basic Metabolic Panel (BMP)  
Potassium6.6 mEq/L (6.6 mmol/L)3.5 to 5 mEq/L (3.5 to 5 mmol/L)
Sodium130 mEq/L (130 mmol/L)136 to 145 mEq/L (136 to 145 mmol/L)
Creatinine1.4 mg/dL (123.8 μmol/L)0.5 to 1.1 mg/dL (44 to 97 μmol/L)
Blood urea nitrogen (BUN)20 mg/dL (7.14 mmol/L)10 to 20 mg/dL (3.6 to 7.1 mmol/L)
Magnesium6 mEq/L (3 mmol/L)1.3 to 2.1 mEq/L (0.65 to 1.05 mmol/L)
pH7.337.35 to 7.45
PaCO₂25 mm Hg35 to 45 mm Hg
HCO₃⁻18 mEq/L (18 mmol/L)21 to 28 mEq/L (21 to 28 mmol/L)
PaO₂80 mm Hg80 to 100 mm Hg

The nurse is reviewing the client's assessment data to prepare the plan of care (POC). Select 3 prescriptions the nurse should perform prior transferring the client.

Answer Options

Hint : 🌹 Assess, prepare, ensure IV access

Correct Answers:

  • Reassess pain level
  • Prepare the client for dialysis
  • Assess peripheral IV (PIV) site for patency

Rationale :

✅ Reassess pain level

🌹 The client received morphine 1 mg IV push at 1500, making reassessment of pain an important follow-up intervention.

🌹 After administering an opioid, the nurse evaluates whether the medication achieved the intended analgesic effect.

🌹 Reassessment also identifies adverse effects such as sedation, hypotension, or respiratory depression.

🌹 The client's earlier chest pain makes evaluation particularly important because persistent pain could indicate continued clinical instability.

🌹 The nurse should compare the client's current pain level with the assessment obtained before administering morphine.

🌹 The client's respiratory status should also be reassessed because morphine can suppress respirations.

🌹 Evaluation of medication effectiveness is an essential component of safe medication administration.

🌹 Therefore, the nurse should reassess the client's pain before transferring him to dialysis.

✅ Prepare the client for dialysis

🌹 The client has ESRD with severe oliguria, producing less than 100 mL of urine during 24 hours.

🌹 The potassium level of 6.6 mEq/L represents severe hyperkalemia and has already produced ECG abnormalities and dysrhythmia.

🌹 Temporary measures such as albuterol and sodium polystyrene sulfonate have been initiated, but the client still requires definitive management of the consequences of renal failure.

🌹 The provider specifically prescribed transfer for hemodialysis as soon as the dialysis unit can begin treatment.

🌹 A tunneled dialysis catheter has already been inserted and its placement has been confirmed by chest x-ray.

🌹 Hemodialysis can directly remove excess potassium and other retained solutes from the bloodstream.

🌹 The nurse should ensure that the client is appropriately prepared and that necessary information accompanies the client during transfer.

🌹 Therefore, preparing the client for dialysis is a priority before transfer.

✅ Assess peripheral IV (PIV) site for patency

🌹 The client has a peripheral IV access device, which should be assessed before transfer to another treatment area.

🌹 The nurse should verify patency and assess for infiltration, extravasation, phlebitis, or other complications.

🌹 A functioning IV provides immediate vascular access if additional IV medications or emergency interventions become necessary.

🌹 This client remains clinically high risk because the heart rate continues to be irregular.

🌹 Hyperkalemia-associated dysrhythmias can deteriorate rapidly, making reliable vascular access particularly important.

🌹 The client has also recently received IV labetalol and IV morphine, further supporting assessment of the IV site.

🌹 Identifying an IV complication before transport allows the nurse to correct the problem before the client leaves the unit.

🌹 Therefore, assessing PIV patency is an appropriate action before transferring the client.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

🚀 Upgrade and Unlock all Questions !
5 :

74-year-old male client comes to emergency department (ED) with symptoms of feeling weak, extreme tiredness and lack of appetite for 4 days.

0800

 

Client has a diagnosis of end stage renal disease (ESRD) and was supposed to go to the hospital to start dialysis but did not have transportation. Peripheral IV (PIV) access device inserted, and STAT laboratory specimens drawn. Connected to continuous cardiac monitoring.

 

0810

 

Mucous membranes dry. Capillary refill greater than 3 seconds. Able to void, but urinary output less than 100 mL/24 hours. Weight 188 lb (85.45 kg).

 

1000

 

A Client states, "My heart feels funny and my chest hurts." Notified healthcare provider (HCP). Received prescription for care.

 

1100

 

Electrocardiogram (ECG) shows elevated T waves and dysrhythmia. Polystyrene sulfonate 50 grams administered via rectum. Nebulizer treatment with albuterol 10 mg started. Placed on continuous monitoring

 

1300

Client reports chest pain has now decreased to a 4 on a 0 to 10 scale. Interventional radiology called and can now perform insertion of dialysis catheter. Client prepared for transport. Had small bowel movement since administration of polystyrene sulfonate.

 

1330

Transported to interventional radiology.

 

1500

Returned from interventional radiology. Right subclavian dialysis catheter in place. Dressing is intact. Client is experiencing pain at the insertion site. Notified HCP. Received prescription for pain medication.

 

1520

Administered morphine 1 mg IV push (IVP) for pain of 6 on a 0 to 10 scale.

1545

Reports pain is now 2 on a 0 to 10 scale.

Notified dialysis unit that client is ready to start dialysis.

0810

Vital signs

Heart rate: 126 beats/minute and irregular

Respirations: 24 breaths/minute and shallow

Blood pressure: 166/104 mm Hg

Oxygen saturation: 92% on room air

 

1000

 

Vital signs

Heart rate: 120 beats/minute and irregular

Blood pressure: 170/108 mm Hg

 

1300

Vital signs

Heart rate: 108 beats/minute and continues to be irregular

Respirations: 20 breaths/minute

Blood pressure: 152/94 mm Hg

0800

Admit to hospital for insertion of subclavian dialysis catheter. Send to interventional radiology for insertion STAT

Begin hemodialysis as soon as catheter in place and verified by x-ray

Repeat basic metabolic panel (BMP) and complete blood count (CBC) at the end of first dialysis and every six hours thereafter

Weigh daily

 

1000

12-lead electrocardiogram (ECG) STAT

STAT electrolyte panel

Administer polystyrene sulfonate 50 g via rectum

Administer albuterol 10 mg nebulize treatment over 10 to 15 minutes x 1

Labetalol 20 mg IV push (IVP) now. May repeat dose in 20 minutes if needed. Blood pressure goal is less than 150/90

 

1500

Morphine 1 mg IVP now

Transfer to dialysis as soon as unit can start dialysis

1600

Transfer client to dialysis unit

Laboratory TestResultReference Range
Basic Metabolic Panel (BMP)  
Potassium6.6 mEq/L (6.6 mmol/L)3.5 to 5 mEq/L (3.5 to 5 mmol/L)
Sodium130 mEq/L (130 mmol/L)136 to 145 mEq/L (136 to 145 mmol/L)
Creatinine1.4 mg/dL (123.8 μmol/L)0.5 to 1.1 mg/dL (44 to 97 μmol/L)
Blood urea nitrogen (BUN)20 mg/dL (7.14 mmol/L)10 to 20 mg/dL (3.6 to 7.1 mmol/L)
Magnesium6 mEq/L (3 mmol/L)1.3 to 2.1 mEq/L (0.65 to 1.05 mmol/L)
Arterial Blood Gas  
pH7.337.35 to 7.45
PaCO₂25 mm Hg35 to 45 mm Hg
HCO₃⁻18 mEq/L (18 mmol/L)21 to 28 mEq/L (21 to 28 mmol/L)
PaO₂80 mm Hg80 to 100 mm Hg

Tunneled subclavian 16 French (Fr) triple lumen dialysis catheter placed in interventional radiology. Placement confirmed via chest x-ray.

The nurse will prepare the client for transfer to the dialysis unit. Which action(s) should the nurse take? Select all that apply.

Answer Options

Hint : ✏️ Identify, assess, weigh, and handoff

Correct Answers:

  • Verify identification bracelet is in place
  • Obtain vital signs
  • Weigh the client
  • Provide situation background assessment recommendation (SBAR) report to the dialysis nurse

Rationale :

✅ Verify identification bracelet is in place

✏️ The nurse should verify that the client's identification bracelet is present and accurate before transfer.

✏️ Correct identification is essential before hemodialysis, medication administration, laboratory testing, and other procedures.

✏️ The dialysis staff will use approved identifiers to confirm the correct client before initiating treatment.

✏️ Proper identification reduces the risk of wrong-client treatment and medication errors.

✏️ This client is moving between different hospital departments, making reliable identification particularly important.

✏️ The nurse should ensure that the bracelet remains legible and securely attached.

✏️ Identification verification is a fundamental component of safe transfer procedures.

✏️ Therefore, ensuring the identification bracelet is in place is appropriate before transfer.

✅ Obtain vital signs

✏️ The nurse should obtain current vital signs immediately before transferring this clinically unstable client.

✏️ The client has experienced hypertension, tachycardia, and an irregular cardiac rhythm, making reassessment particularly important.

✏️ Severe hyperkalemia places the client at continued risk for potentially life-threatening cardiac dysrhythmias.

✏️ Recent administration of IV morphine also requires monitoring of respiratory rate, blood pressure, and level of consciousness.

✏️ Baseline vital signs provide the dialysis team with information for comparison during hemodialysis.

✏️ Hemodialysis can cause significant changes in blood pressure and fluid status, making an accurate pre-dialysis measurement important.

✏️ Any significant deterioration identified before transport should be addressed rather than simply transferring the client.

✏️ Therefore, obtaining current vital signs is an appropriate pre-transfer action.

✅ Weigh the client

✏️ A pre-dialysis weight is essential because body weight provides an important assessment of the client's current fluid status.

✏️ Hemodialysis removes excess fluid and solutes from the bloodstream.

✏️ The pre-dialysis weight helps establish a baseline for determining the amount of fluid removal required.

✏️ Comparing pre- and post-dialysis weights helps determine the amount of fluid removed during treatment.

✏️ Approximately 1 kg of body-weight change corresponds to about 1 L of fluid when the change is attributable to fluid balance.

✏️ The provider has also specifically prescribed daily weights, reinforcing the importance of weight monitoring.

✏️ Consistent weighing is particularly important in clients with ESRD, who cannot effectively regulate fluid balance through normal renal excretion.

✏️ Therefore, obtaining the client's weight before transfer for dialysis is appropriate.

✅ Provide SBAR report to the dialysis nurse

✏️ A structured SBAR handoff promotes safe communication when transferring responsibility for the client's care.

✏️ The report should include the client's ESRD, severe hyperkalemia, ECG abnormalities, and current cardiovascular status.

✏️ The nurse should communicate that the client received polystyrene sulfonate, nebulized albuterol, labetalol, and morphine.

✏️ The newly inserted right subclavian dialysis catheter and confirmation of its placement should also be reported.

✏️ Current vital signs, pain status, laboratory results, and relevant assessment findings provide the receiving nurse with an appropriate clinical baseline.

✏️ The dialysis nurse should be informed that the potassium was 6.6 mEq/L with elevated T waves and dysrhythmia.

✏️ Effective handoff reduces the risk of omitted information and supports continuity of care.

✏️ Therefore, providing an SBAR report before transfer is essential.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

🚀 Upgrade and Unlock all Questions !
6 :

74-year-old male client comes to emergency department (ED) with symptoms of feeling weak, extreme tiredness and lack of appetite for 4 days.

0800

 

Client has a diagnosis of end stage renal disease (ESRD) and was supposed to go to the hospital to start dialysis but did not have transportation. Peripheral IV (PIV) access device inserted, and STAT laboratory specimens drawn. Connected to continuous cardiac monitoring.

 

0810

 

Mucous membranes dry. Capillary refill greater than 3 seconds. Able to void, but urinary output less than 100 mL/24 hours. Weight 188 lb (85.45 kg).

 

1000

 

A Client states, "My heart feels funny and my chest hurts." Notified healthcare provider (HCP). Received prescription for care.

 

1100

 

Electrocardiogram (ECG) shows elevated T waves and dysrhythmia. Polystyrene sulfonate 50 grams administered via rectum. Nebulizer treatment with albuterol 10 mg started. Placed on continuous monitoring

 

1300

Client reports chest pain has now decreased to a 4 on a 0 to 10 scale. Interventional radiology called and can now perform insertion of dialysis catheter. Client prepared for transport. Had small bowel movement since administration of polystyrene sulfonate.

 

1330

Transported to interventional radiology.

 

1500

Returned from interventional radiology. Right subclavian dialysis catheter in place. Dressing is intact. Client is experiencing pain at the insertion site. Notified HCP. Received prescription for pain medication.

 

1520

Administered morphine 1 mg IV push (IVP) for pain of 6 on a 0 to 10 scale.

1545

Reports pain is now 2 on a 0 to 10 scale.

Notified dialysis unit that client is ready to start dialysis.

 

1615

Situation background assessment recommendation (SBAR) report given to dialysis nurse. Reported type of catheter placed, size and location. Catheter flushed with 10 mL saline in each lumen and 500 units of heparin instilled in each unit by interventional radiologist at time of placement. Current blood pressure 152/94 mm Hg after 1 dose of labetalol. Received polystyrene sulfonate 50 g via rectum and 1 dose of nebulized albuterol 10 mg for potassium level of 6.7 mEq/L (6.7 mmol/L).

 

2100

Returned to room after receiving first hemodialysis. Dialysis nurse reports tolerated dialysis well with only 1 episode of hypotension. Wet weight 190 lb. (86.4 kg). Dry weight 185 lb. (84 kg). Client reports feeling very tired and wants to rest.

0810

Vital signs

Heart rate: 126 beats/minute and irregular

Respirations: 24 breaths/minute and shallow

Blood pressure: 166/104 mm Hg

Oxygen saturation: 92% on room air

 

1000

 

Vital signs

Heart rate: 120 beats/minute and irregular

Blood pressure: 170/108 mm Hg

 

1300

Vital signs

Heart rate: 108 beats/minute and continues to be irregular

Respirations: 20 breaths/minute

Blood pressure: 152/94 mm Hg

0800

Admit to hospital for insertion of subclavian dialysis catheter. Send to interventional radiology for insertion STAT

Begin hemodialysis as soon as catheter in place and verified by x-ray

Repeat basic metabolic panel (BMP) and complete blood count (CBC) at the end of first dialysis and every six hours thereafter

Weigh daily

 

1000

12-lead electrocardiogram (ECG) STAT

STAT electrolyte panel

Administer polystyrene sulfonate 50 g via rectum

Administer albuterol 10 mg nebulize treatment over 10 to 15 minutes x 1

Labetalol 20 mg IV push (IVP) now. May repeat dose in 20 minutes if needed. Blood pressure goal is less than 150/90

 

1500

Morphine 1 mg IVP now

Transfer to dialysis as soon as unit can start dialysis

1600

Transfer client to dialysis unit

 

2100

Weigh daily

Vital signs every 4 hours and PRN

Dialysis three times weekly

Schedule surgery for placement of arteriovenous (AV) fistula

Phosphate binders 1 tablet three times daily with meals

Restrict fluids to 1,000 mL/day

BMP and CBC every 6 hours

Dialysis catheter care

Chest x-ray in morning

Incentive spirometry

Erythropoietin 2,000 units subcutaneous three times weekly until hemoglobin levels above 11 g/dL (6.83 mmol/L)

Protein, sodium, and phosphorous restricted diet

Laboratory TestResultReference Range
Basic Metabolic Panel (BMP)  
Potassium6.6 mEq/L (6.6 mmol/L)3.5 to 5 mEq/L (3.5 to 5 mmol/L)
Sodium130 mEq/L (130 mmol/L)136 to 145 mEq/L (136 to 145 mmol/L)
Creatinine1.4 mg/dL (123.8 μmol/L)0.5 to 1.1 mg/dL (44 to 97 μmol/L)
Blood urea nitrogen (BUN)20 mg/dL (7.14 mmol/L)10 to 20 mg/dL (3.6 to 7.1 mmol/L)
Magnesium6 mEq/L (3 mmol/L)1.3 to 2.1 mEq/L (0.65 to 1.05 mmol/L)
Arterial Blood Gas  
pH7.337.35 to 7.45
PaCO₂25 mm Hg35 to 45 mm Hg
HCO₃⁻18 mEq/L (18 mmol/L)21 to 28 mEq/L (21 to 28 mmol/L)
PaO₂80 mm Hg80 to 100 mm Hg

Tunneled subclavian 16 French (Fr) triple lumen dialysis catheter placed in interventional radiology. Placement confirmed via chest x-ray.

For each body system, click to specify the intervention that would be appropriate for the care of the client at this time. Each body system may support more than one potential nursing intervention. Each category must have at least one option selected,,,, and .

Hint : ❤️ Follow current post-dialysis prescriptions

Correct Answers

  • Blank 1 Correct Option: Fluid restriction
  • Blank 2 Correct Option: Vital signs every 4 hours and PRN
  • Blank 3 Correct Option: Administer phosphate binders at meals
  • Blank 4 Correct Option: Administer erythropoietin 2,000 units
  • Blank 5 Correct Option: Dialysis catheter care
  • Blank 6 Correct Option: Chest x-ray
  • Blank 7 Correct Option: Incentive spirometry every 1 hour
Rationale :

✅ Cardiovascular Rationales

Fluid restriction — Appropriate

❤️ The client has ESRD, which severely limits the kidneys' ability to regulate fluid balance.

❤️ The provider specifically prescribed a 1,000 mL/day fluid restriction after dialysis.

❤️ Fluid restriction helps prevent fluid volume overload between dialysis treatments.

❤️ Excessive fluid accumulation can contribute to hypertension, peripheral edema, and pulmonary congestion.

❤️ The client's wet weight is 190 lb compared with a dry weight of 185 lb, indicating excess fluid weight.

❤️ Monitoring fluid intake is therefore an important component of ongoing cardiovascular and renal management.

❤️ Daily weights should accompany fluid restriction because weight changes provide a sensitive indicator of fluid accumulation.

❤️ Therefore, fluid restriction is appropriate for the client's current care.

Vital signs every 4 hours and PRN — Appropriate

❤️ The provider specifically prescribed vital signs every 4 hours and PRN following the client's first dialysis treatment.

❤️ The client experienced an episode of hypotension during dialysis, making continued blood pressure monitoring particularly important.

❤️ Hemodialysis can cause hypotension because fluid is removed from the intravascular compartment.

❤️ The client previously had significant hypertension and an irregular heart rhythm, requiring continued cardiovascular assessment.

❤️ Monitoring heart rate can identify persistence or recurrence of dysrhythmias associated with electrolyte abnormalities.

❤️ Blood pressure trends help determine the client's response to fluid removal and antihypertensive therapy.

❤️ PRN assessment allows additional measurements whenever the client's clinical condition changes.

❤️ Therefore, scheduled and PRN vital-sign monitoring is appropriate.

Administer labetalol 20 mg IV push — Not currently indicated

❤️ The labetalol prescription was given earlier for severe hypertension, with repeat dosing permitted after 20 minutes if needed.

❤️ The client already received the initial dose and subsequently underwent hemodialysis.

❤️ The client experienced an episode of hypotension during dialysis, increasing concern about unnecessary additional antihypertensive administration.

❤️ A new current blood pressure should guide any further intervention rather than automatically repeating the earlier IV labetalol prescription.

✅ Renal Rationales

Administer phosphate binders at meals — Appropriate

❤️ Clients with ESRD have impaired renal elimination of phosphate, increasing the risk of hyperphosphatemia.

❤️ The provider prescribed a phosphate binder three times daily with meals.

❤️ Phosphate binders work within the gastrointestinal tract by binding dietary phosphate.

❤️ Binding phosphate decreases its intestinal absorption into the bloodstream.

❤️ These medications are most effective when administered with meals, when dietary phosphorus is present.

❤️ Controlling phosphorus is important for reducing complications of CKD-mineral and bone disorder.

❤️ The nurse should therefore coordinate administration of the prescribed binder with the client's meals.

❤️ This is an appropriate ongoing intervention for the client's ESRD management.

Administer erythropoietin 2,000 units — Appropriate

❤️ ESRD reduces the kidneys' ability to produce adequate erythropoietin.

❤️ Reduced erythropoietin contributes to decreased red blood cell production and anemia of chronic kidney disease.

❤️ The provider specifically prescribed erythropoietin 2,000 units subcutaneously three times weekly.

❤️ Erythropoietin stimulates the bone marrow to increase red blood cell production.

❤️ Treatment can improve manifestations such as fatigue and reduced exercise tolerance when anemia is present.

❤️ Hemoglobin levels should be monitored to evaluate the client's response to treatment.

❤️ The prescription specifies administration until the client's hemoglobin exceeds the stated target.

❤️ Therefore, administering erythropoietin as prescribed is an appropriate renal intervention.

Dialysis catheter care — Appropriate

❤️ The client has a newly inserted tunneled subclavian dialysis catheter that requires careful ongoing management.

❤️ The catheter provides vascular access for the client's scheduled hemodialysis treatments.

❤️ Strict aseptic technique is essential because central dialysis catheters create a significant risk for bloodstream infection.

❤️ The catheter site and dressing should be assessed for bleeding, drainage, redness, swelling, or other abnormalities.

❤️ The dressing should remain clean, dry, and intact according to facility protocol.

❤️ The catheter should only be accessed and maintained according to established dialysis catheter procedures.

❤️ Proper catheter care helps maintain patency and prevents potentially serious complications.

❤️ Therefore, dialysis catheter care is an appropriate ongoing renal intervention.

✅ Respiratory Rationales

Chest x-ray — Appropriate

❤️ The provider specifically prescribed a chest x-ray in the morning.

❤️ The client recently underwent placement of a right subclavian dialysis catheter.

❤️ Central venous catheter placement can be associated with thoracic complications such as pneumothorax.

❤️ Chest imaging can evaluate the lungs and catheter-related thoracic findings after the procedure.

❤️ The client's respiratory status also warrants observation because ESRD can contribute to fluid-related pulmonary complications.

❤️ The client's initial oxygen saturation was 92% on room air, supporting continued respiratory assessment.

❤️ The nurse should therefore ensure that the prescribed follow-up imaging is completed.

❤️ The chest x-ray is an appropriate intervention according to the current plan of care.

Incentive spirometry every 1 hour — Appropriate

❤️ Incentive spirometry encourages sustained deep inspiration and promotes lung expansion.

❤️ The client has undergone a procedure and has received morphine, both of which can contribute to decreased respiratory effort.

❤️ The initial respiratory assessment documented shallow respirations, making pulmonary expansion exercises beneficial.

❤️ Incentive spirometry can help reduce the risk of atelectasis associated with reduced deep breathing.

❤️ The provider specifically included incentive spirometry in the post-dialysis plan of care.

❤️ The nurse should instruct the client in proper technique and encourage regular use while awake.

❤️ Respiratory status and tolerance should continue to be assessed during its use.

❤️ Therefore, incentive spirometry is an appropriate respiratory intervention.

Administer sodium polystyrene sulfonate — Not currently indicated

❤️ Sodium polystyrene sulfonate was previously administered for the client's severe hyperkalemia.

❤️ The client has now undergone hemodialysis, which provides direct removal of potassium from the bloodstream.

❤️ There is no new prescription for another dose, and post-dialysis laboratory values are ordered to determine the client's current potassium level.

❤️ Therefore, another dose should not be administered without a current indication and prescription.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

🚀 Upgrade and Unlock all Questions !
7 :

74-year-old male client comes to emergency department (ED) with symptoms of feeling weak, extreme tiredness and lack of appetite for 4 days.

0800

 

Client has a diagnosis of end stage renal disease (ESRD) and was supposed to go to the hospital to start dialysis but did not have transportation. Peripheral IV (PIV) access device inserted, and STAT laboratory specimens drawn. Connected to continuous cardiac monitoring.

 

0810

 

Mucous membranes dry. Capillary refill greater than 3 seconds. Able to void, but urinary output less than 100 mL/24 hours. Weight 188 lb (85.45 kg).

 

1000

 

A Client states, "My heart feels funny and my chest hurts." Notified healthcare provider (HCP). Received prescription for care.

 

1100

 

Electrocardiogram (ECG) shows elevated T waves and dysrhythmia. Polystyrene sulfonate 50 grams administered via rectum. Nebulizer treatment with albuterol 10 mg started. Placed on continuous monitoring

 

1300

Client reports chest pain has now decreased to a 4 on a 0 to 10 scale. Interventional radiology called and can now perform insertion of dialysis catheter. Client prepared for transport. Had small bowel movement since administration of polystyrene sulfonate.

 

1330

Transported to interventional radiology.

 

1500

Returned from interventional radiology. Right subclavian dialysis catheter in place. Dressing is intact. Client is experiencing pain at the insertion site. Notified HCP. Received prescription for pain medication.

 

1520

Administered morphine 1 mg IV push (IVP) for pain of 6 on a 0 to 10 scale.

1545

Reports pain is now 2 on a 0 to 10 scale.

Notified dialysis unit that client is ready to start dialysis.

 

1615

Situation background assessment recommendation (SBAR) report given to dialysis nurse. Reported type of catheter placed, size and location. Catheter flushed with 10 mL saline in each lumen and 500 units of heparin instilled in each unit by interventional radiologist at time of placement. Current blood pressure 152/94 mm Hg after 1 dose of labetalol. Received polystyrene sulfonate 50 g via rectum and 1 dose of nebulized albuterol 10 mg for potassium level of 6.7 mEq/L (6.7 mmol/L).

 

2100

Returned to room after receiving first hemodialysis. Dialysis nurse reports tolerated dialysis well with only 1 episode of hypotension. Wet weight 190 lb. (86.4 kg). Dry weight 185 lb. (84 kg). Client reports feeling very tired and wants to rest.

 

Day 2

 

0700

Client has new placement of arteriovenous (AV) graft in right forearm. Bruit and thrill present. Area is tender but has minimal pain. Subclavian dialysis catheter remains in place. Dressing is dry and intact. Weight gain of 2 lb. (0.9 kg) in 24 hours. Blood pressure is 154/94 mm Hg. Intake for past 12 hours 600 mL. Lung sounds have crackles in all lung fields. Client reports being very tired. Describes feeling short of breath when walking. Mucous membranes moist. Capillary refill less than 4 seconds. 2+ edema lower extremities.

0810

Vital signs

Heart rate: 126 beats/minute and irregular

Respirations: 24 breaths/minute and shallow

Blood pressure: 166/104 mm Hg

Oxygen saturation: 92% on room air

 

1000

 

Vital signs

Heart rate: 120 beats/minute and irregular

Blood pressure: 170/108 mm Hg

 

1300

Vital signs

Heart rate: 108 beats/minute and continues to be irregular

Respirations: 20 breaths/minute

Blood pressure: 152/94 mm Hg

 

2100

Vital signs

Temperature: 98.8° F (37.1°C) orally

Heart rate: 90 beats/minute

Respirations: 22 breaths/minute

Blood pressure: 118/72 mm Hg

Day 2

0000

Vital signs

Temperature: 98.6° F (37° C) orally

Heart rate: 88 beats/minute

Respirations: 20 breaths/minute

Blood pressure: 130/76 mm Hg

0800

Admit to hospital for insertion of subclavian dialysis catheter. Send to interventional radiology for insertion STAT

Begin hemodialysis as soon as catheter in place and verified by x-ray

Repeat basic metabolic panel (BMP) and complete blood count (CBC) at the end of first dialysis and every six hours thereafter

Weigh daily

 

1000

12-lead electrocardiogram (ECG) STAT

STAT electrolyte panel

Administer polystyrene sulfonate 50 g via rectum

Administer albuterol 10 mg nebulize treatment over 10 to 15 minutes x 1

Labetalol 20 mg IV push (IVP) now. May repeat dose in 20 minutes if needed. Blood pressure goal is less than 150/90

 

1500

Morphine 1 mg IVP now

Transfer to dialysis as soon as unit can start dialysis

1600

Transfer client to dialysis unit

 

2100

Weigh daily

Vital signs every 4 hours and PRN

Dialysis three times weekly

Schedule surgery for placement of arteriovenous (AV) fistula

Phosphate binders 1 tablet three times daily with meals

Restrict fluids to 1,000 mL/day

BMP and CBC every 6 hours

Dialysis catheter care

Chest x-ray in morning

Incentive spirometry

Erythropoietin 2,000 units subcutaneous three times weekly until hemoglobin levels above 11 g/dL (6.83 mmol/L)

Protein, sodium, and phosphorous restricted diet

Laboratory TestResultReference Range
Basic Metabolic Panel (BMP)  
Potassium6.6 mEq/L (6.6 mmol/L)3.5 to 5 mEq/L (3.5 to 5 mmol/L)
Sodium130 mEq/L (130 mmol/L)136 to 145 mEq/L (136 to 145 mmol/L)
Creatinine1.4 mg/dL (123.8 μmol/L)0.5 to 1.1 mg/dL (44 to 97 μmol/L)
Blood urea nitrogen (BUN)20 mg/dL (7.14 mmol/L)10 to 20 mg/dL (3.6 to 7.1 mmol/L)
Magnesium6 mEq/L (3 mmol/L)1.3 to 2.1 mEq/L (0.65 to 1.05 mmol/L)
pH7.337.35 to 7.45
PaCO₂25 mm Hg35 to 45 mm Hg
HCO₃⁻18 mEq/L (18 mmol/L)21 to 28 mEq/L (21 to 28 mmol/L)
PaO₂80 mm Hg80 to 100 mm Hg

Tunneled subclavian 16 French (Fr) triple lumen dialysis catheter placed in interventional radiology. Placement confirmed via chest x-ray.

Click to highlight the concerns the nurse would need to address in their assessment of the client.

Day 2 0700 Client has new placement of AV graft in right forearm. Bruit and thrill present. Area is tender but has minimal pain. Subclavian dialysis catheter remains in place. Dressing is dry and intact. Weight gain of 2 pounds (0.9 kg) in 24 hours. Blood pressure is 154/94 mm Hg. Intake for past 12 hours 600 mL. Lung sounds have crackles in all lung fields. Client reports being very tired. Describes feeling short of breath when walking. Mucous membranes moist. Capillary refill less than 4 seconds. 2+ edema lower extremities. Weight 194 pounds (88 kg).

Hint : 📗 Look for fluid-volume overload

Correct Highlights :
  • Weight gain of 2 pounds (0.9 kg) in 24 hours
  • Blood pressure is 154/94 mm Hg
  • Intake for past 12 hours 600 mL
  • crackles in all lung fields
  • very tired
  • short of breath when walking
  • 2+ edema lower extremities
  • Weight 194 pounds (88 kg)
Rationale :

📗 The client's 2-lb weight gain within 24 hours is concerning for rapid fluid accumulation in a client with ESRD and severely impaired renal fluid excretion.

📗 The current weight of 194 lb is also substantially above the previously documented dry weight of 185 lb, further supporting excess fluid volume.

📗 A blood pressure of 154/94 mm Hg indicates hypertension, which can occur when excess intravascular volume develops in ESRD.

📗 An intake of 600 mL in 12 hours is concerning because the client has a prescribed 1,000-mL/day fluid restriction, leaving only 400 mL for the remaining 12 hours.

📗 Crackles throughout all lung fields are particularly concerning because they can indicate pulmonary fluid accumulation and developing pulmonary congestion.

📗 Shortness of breath with activity further supports impaired respiratory function associated with fluid overload and requires prompt assessment.

📗 2+ lower-extremity edema demonstrates fluid accumulation in the interstitial tissues and supports the presence of excess fluid volume.

📗 The client's marked fatigue also requires follow-up because ESRD can produce fatigue from multiple causes, including anemia, uremia, and fluid-related cardiopulmonary compromise.

Findings Not Highlighted as Current Concerns

Bruit and thrill present is an expected and desirable finding after AV graft placement because it indicates vascular access patency.

Tenderness with minimal pain can be expected following recent AV graft placement when there are no findings suggesting significant bleeding, infection, or vascular compromise.

Subclavian dialysis catheter remains in place with a dry, intact dressing is expected while the new AV access matures and indicates no obvious catheter-site complication.

Moist mucous membranes do not indicate dehydration and are not independently concerning.

Capillary refill less than 4 seconds is somewhat imprecise wording; clinically, ≤2 seconds is typically expected. If the actual refill is 3 seconds, it would warrant follow-up, but the item does not provide a precise value.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

🚀 Upgrade and Unlock all Questions !
8 :

Hint : 📘 A1C shows long-term glucose control

Correct Answers:

  • Review the client's glycosylated hemoglobin A1C (HbA1C) level.

Rationale :

📘 HbA1C provides an estimate of the client's average blood glucose over approximately the previous 2 to 3 months.

📘 The client was diagnosed with type 2 diabetes 3 months ago, making the HbA1C particularly useful for evaluating overall glycemic control since diagnosis.

📘 Fingerstick glucose measurements reflect the blood glucose at specific points in time, whereas HbA1C provides a longer-term picture.

📘 Reviewing the HbA1C helps determine whether the client's report of difficulty controlling glucose represents persistent hyperglycemia rather than isolated elevations.

📘 HbA1C is commonly used to evaluate the effectiveness of diabetes treatment and self-management over time.

📘 The result can help guide decisions about whether changes are needed in the client's diet, physical activity, medication regimen, or diabetes education.

📘 Older adults may have individualized glycemic targets based on overall health and comorbidities, making assessment of the client's long-term glucose trend important.

📘 Therefore, reviewing the client's HbA1C level is the most important intervention among the available options.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

🚀 Upgrade and Unlock all Questions !
9 :

Hint : 🌹 Protect diabetic feet from unnoticed injury

Correct Answers:

  • Check the insides and linings of all enclosed shoes before putting the shoes on.

Rationale :

🌹 Clients with diabetes mellitus can develop peripheral neuropathy, which decreases the ability to detect pain, pressure, heat, and injury in the feet.

🌹 Inspecting the inside of shoes before wearing them helps identify stones, sharp objects, rough seams, or damaged linings that could injure the foot.

🌹 A client with decreased sensation might continue walking with a foreign object in the shoe without realizing that tissue damage is occurring.

🌹 Even a minor injury can progress to a diabetic foot ulcer because diabetes can impair wound healing and increase susceptibility to infection.

🌹 The client's current infected great-toe ulcer demonstrates the importance of preventing additional trauma to the feet.

🌹 Shoes should fit properly and provide adequate protection without creating areas of friction or excessive pressure.

🌹 Clients should also inspect their feet routinely for cuts, blisters, redness, swelling, or other skin changes.

🌹 Therefore, checking the inside and lining of enclosed shoes before putting them on is an essential diabetic foot-care practice.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

🚀 Upgrade and Unlock all Questions !
10 :

Hint : 💎 PKD increases intracranial aneurysm risk

Correct Answers:

  • Complete a neurological assessment.

Rationale :

💎 Clients with polycystic kidney disease (PKD) have an increased risk for intracranial aneurysms.

💎 A sudden or severe headache can indicate rupture or expansion of an intracranial aneurysm and possible subarachnoid hemorrhage.

💎 The nurse should first perform a focused neurological assessment to identify evidence of acute neurologic deterioration.

💎 Assessment should include level of consciousness, orientation, pupils, motor function, speech, and other neurologic findings.

💎 Findings such as altered consciousness, focal neurological deficits, vomiting, or neck stiffness would increase concern for an acute intracranial event.

💎 Early recognition of neurological abnormalities allows rapid notification of the healthcare provider and initiation of appropriate diagnostic evaluation and emergency treatment.

💎 Although hypertension commonly occurs with PKD, the client's severe headache makes assessment for a potentially life-threatening neurologic complication the immediate priority.

💎 Therefore, completing a neurological assessment first provides the most important information for determining the client's immediate condition.

Distractor Analysis :

Rationale for Incorrect Options to be Available Soon

🚀 Upgrade and Unlock all Questions !

Total Questions: 10

Choose Different Exam !